Nestle investors face more turbulence after another CEO ousted

Nestle has replaced CEO Laurent Freixe with Philipp Navratil, marking the second leadership change in a year, following Freixe's dismissal due to a breach of the company's Code of Business Conduct concerning a romantic relationship with a subordinate. This abrupt transition exacerbates Nestle's ongoing challenges, including a significant share price decline and uneven performance since the pandemic, leading analysts to express concerns about the company's mid-term strategic direction and potential for continued pressure on its stock.

Analysis

Nestle is confronting a significant governance and strategic crisis following the abrupt ousting of CEO Laurent Freixe for breaching the company's code of conduct, marking the second CEO change within a year. This leadership turmoil exacerbates an already challenging period for the Swiss food giant, which has seen its share price decline by nearly a third over the past five years, significantly underperforming European peers. Since Freixe's appointment, the stock has fallen an additional 17%, reflecting investor disappointment with the ongoing turnaround efforts. The situation is compounded by existing operational weaknesses, including a review of its underperforming vitamins business initiated after first-half sales volumes missed expectations. Analyst commentary from JP Morgan underscores the market's concern, highlighting that the repeated appointment of a new CEO without a thorough search process undermines investor confidence. Furthermore, there is apprehension that the new CEO, Philipp Navratil, may be constrained by his predecessor's strategy, which has so far failed to convince the market, likely putting a "lid on the equity story" in the near term.

Key Decisions for Investors

• Investors should anticipate continued share price pressure and volatility due to the elevated leadership uncertainty and lack of a clearly articulated strategic direction from the new CEO.
• Potential investors should remain on the sidelines until new CEO Philipp Navratil provides a comprehensive strategic plan that addresses the company's underperformance and outlines a clear path to a turnaround.
• Existing shareholders should closely monitor for any announcements regarding the strategic review of the vitamins business and initial guidance from the new leadership, as these will be key catalysts for re-evaluating the investment thesis.